Author

Yi Xia

h-index 9 View on Semantic Scholar

We have 2 of 59 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Improved efficacy of Orelabrutinib plus Rituximab, Temozolomide and High-Dose Methotrexate (RMOT) vs. RMT in untreated primary CNS lymphoma: A matched analysis

Primary central nervous system lymphoma (PCNSL) is a rare, aggressive malignant tumor with poor prognosis, and the optimal standard treatment remains undefined. This study aimed to compare the efficacy and safety of rituximab, high-dose methotrexate plus temozolomide (RMT regimen) and orelabrutinib plus RMT (RMOT...

Peng Zhang, Man Nie, Hang Yang et al. · Neuro-Oncology Advances · 0 citations

Open access Jul 2026

Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications

This study provides a high-resolution molecular atlas of NKTCL heterogeneity, offering insights into patient stratification and potential avenues for future therapeutic development.

Yi Cao, Jun Cai, Danling Dai et al. · Nature Communications · 0 citations